GTHX - G1 Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

G1 Therapeutics's activity chart (see below) currently has 75 price targets and 76 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.88% with an average time for these price targets to be met of 58.45 days.

Most recent stock forecast was given by from NEEDHAM on 07-Aug-2024. First documented stock forecast 12-Jun-2017.

Best performing analysts who are covering GTHX - G1 Therapeutics:

Chad Messer Anupam Rama David Nierengarten Dane Leone Gil Blum Edward White

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 05-May-2022

$6

2 years 2 months 1 days ago
(07-Aug-2024)

1/12 (8.33%)

$3.8 (172.73%)

43

Sell Since 07-Aug-2024

$7.15

2 years 2 months 1 days ago
(07-Aug-2024)

5/7 (71.43%)

$0.09 (1.27%)

39

Buy Since 26-Jun-2020

2 years 2 months 1 days ago
(07-Aug-2024)

0/3 (0%)

$37.84 (234.16%)

Buy Since 17-Sep-2018

$3

$-4.15 (-58.04%)

$9

2 years 3 months 13 days ago
(25-Jun-2024)

1/13 (7.69%)

$0.8 (36.36%)

17

Buy Since 16-Sep-2022

$4

$-3.15 (-44.06%)

$5

2 years 7 months 25 days ago
(13-Feb-2024)

4/9 (44.44%)

$1.9 (90.48%)

189

Show more analysts

Please expand the browser size to see the chart

What is GTHX (G1 Therapeutics) average time for price targets to be met?

On average it took 58 days for the stock forecasts to be reached, with an average price target met ratio of 22.88%.

Which analyst most recently updated their price target on GTHX (G1 Therapeutics)?

Which analyst has the most public recommendations on GTHX (G1 Therapeutics)?

has 0 price targets and 0 ratings on GTHX

Which analyst is the currently most bullish on GTHX (G1 Therapeutics)?

Chad Messer with the highest potential upside of $60.85

Which analyst is the currently most reserved on GTHX (G1 Therapeutics)?

Edward White with the lowest potential downside of -$4.15
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?